-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Alopecia areata (AA) is an autoimmune disease in which scarless patches of hair loss can occur
.
Associated with other autoimmune diseases and increased risk of cardiovascular and metabolic diseases, this article analyzes the prevalence of cardiac and metabolic diseases in patients with type AA
In this study, the data comes from the Explorys electronic aggregation database, which is composed of more than 50 million patients from 360 hospitals in the United States
.
Three AA patients were identified using the SNOMED-CT term "alopecia areata" (n=33,130 patients)
In our patients with alopecia areata, in addition to myocardial infarction, the prevalence of cardiac and metabolic disorders is higher
.
A study found that patients with alopecia areata are less likely to develop acute myocardial infarction and stroke
Further research is needed to confirm these findings and examine the correlation between the severity of AA in successful treatment and the prevalence of metabolism and heart disease
Literature source: Conic RRZ, Chu S, Tamashunas NL, J Eur Acad Dermatol VenereolLeave a message here